AZD3241

DRUG3 trials

Sponsors

AstraZeneca

Conditions

HealthyHealthy VolunteersMultiple System Atrophy, MSA

Phase 1

Investigating Safety, Tolerability and Pharmakinetics When Giving Single and Fractionated Doses of AZD3241 to Healthy Volunteers

CompletedNCT00729443

AstraZenecaHealthy Volunteers

Start: 2008-07-31End: 2008-11-30Target: 64Updated: 2008-11-13

Study to Evaluate Different Extended Release (ER)-Formulations and Multiple Ascending Dosing of AZD3241

CompletedNCT00914303

AstraZenecaHealthy

Start: 2009-06-30End: 2010-03-31Updated: 2010-04-06

Phase 2

AZD3241 PET MSA Trial, Phase 2, Randomized,12 Week Safety and Tolerability Trial With PET in MSA Patients

CompletedNCT02388295

AstraZenecaMultiple System Atrophy, MSA

Start: 2015-04-27End: 2016-09-19Updated: 2017-09-25